中康控股2023 年度报告

Contents 2Corporate Information6Core Financial and Operational Data8Financial Summary9Chairman’s Statement14Management Discussion and Analysis41Directors and Senior Management50Directors’ Report88Corporate Governance Report106Environmental, Social and Governance Report166Independent Auditor’s Report177Consolidated Statement of Profit or Loss andOther Comprehensive Income178Consolidated Statement of Financial Position180Consolidated Statement of Changes in Equity182Consolidated Statement of Cash Flows186Notes to Financial Statements311Definitions 2CORPORATE INFORMATION BOARD OF DIRECTORSExecutive DirectorsMr. Wu Yushu(Chairman)Ms. Wang Lifang Non-executive DirectorMr. Fu Haitao Independent Non-executive DirectorsMs. Wang DanzhouMs. Du YilinMr. Wei Bin AUDIT COMMITTEE Mr. Wei Bin(Chairman)Ms. Wang DanzhouMs. Du Yilin REMUNERATION COMMITTEE Ms. Wang Danzhou(Chairman)Ms. Du YilinMs. Wang Lifang NOMINATION COMMITTEE Mr. Wu Yushu(Chairman)Ms. Du YilinMs. Wang Danzhou AUTHORISED REPRESENTATIVES Mr. Wu YushuMs. Zhang Xiao ACGHKACG JOINT COMPANY SECRETARIES Mr. Wan ChuanMs. Zhang XiaoACG, HKACG REGISTERED OFFICE IN THE CAYMAN ISLANDS 89 Nexus WayCamana BayGrand Cayman KY1-9009Cayman Islands 89 Nexus WayCamana BayGrand Cayman KY1-9009Cayman Islands PRINCIPAL PLACE OF BUSINESS IN THE PRC Room 1111, No.5 Wangjiang Second StreetHuangge Town, Nansha DistrictGuangzhou CityGuangdong ProvincePRC 51111 PRINCIPAL PLACE OF BUSINESS IN HONG KONG 1357732 Room 732, 7th Floor, Rykadan Tower135 Hoi Bun Road, Kwun TongKowloonHong Kong CAYMAN ISLANDS PRINCIPAL SHAREREGISTRAR AND TRANSFER OFFICE Ogier GlobalCayman Limited89 Nexus WayCamana BayGrand Cayman KY1-9009Caym an Islands Ogier Global (Cayman) Limited89 Nexus WayCamana BayGrand Cayman KY1-9009Cayman Islands HONG KONG SHARE REGISTRAR ANDTRANSFER OFFICE 148212103B Boardroom Share Registrars (HK) Limited2103B,21/F148 Electric RoadNorth PointHong Kong 4CORPORATE INFORMATION COMPLIANCE ADVISER 83 Giraffe Capital Limited3/F,8 Wyndham StreetCentralHong Kong LEGAL ADVISERS 15323203-3207 As to Hong Kong lawJingtian & Gongcheng LLPSuites 3203-320732/F, Edinburgh TowerThe Landmark15 Queen’s Road CentralHong Kong 101045 As to PRC lawJingtian & Gongcheng45/F, K.Wah Centre1010 Huaihai Road (M)ShanghaiChina AUDITOR 979127 Ernst& YoungCertified Public AccountantsRegistered Public Interest Entity Auditor27/F, One Taikoo Place979 King’s RoadQuarry BayHong Kong PRINCIPALBANK 76 Ping An Bank Guangzhou Huangpu Avenue Branch1/F, Fulilong SquareNo. 76 Huangpu Avenue WestTianhe DistrictGuangzhou CityGuangdong ProvincePRC 2361 STOCK CODE2361 ir.sinohealth.cn COMPANY’S WEBSITEir.sinohealth.cn CORE FINANCIAL AND OPERATIONAL DATA6 FINANCIAL SUMMARY8 20222023123120222019202020211231 The following is a summary of the Group’s publishedresults and assets and liabilities for the past five financialyears. The financial information for the year ended31 December 2022 and 2023 is extracted from theconsolidated financial statements of 2022 and this annualreport, and the financial information for the years ended31 December 2019, 2020 and 2021 is extracted from theProspectus. 2023 At CPEO held in 2023, we put forward our study resultson the industry titled “Dual Synergy Reshapes the Industry– Opens a New Era of Personal Health Responsibility”,that is, along with the increasing importance and concernof national health, the “healthcare” demand is gettinggreater than “medical” demand in the society. China isentering into the new era of personal health responsibility,so the promotion of healthcare industry will enter intothe new phase of concerted development of both seriousmedical industry and consumer medical industry to meetthe national requirements for full life cycle health security.To meet the diversified and personalised healthcaredemands, the healthcare industry needs support ofmassive data and digital tools, and health big data anddigital products will embrace explosive growth, drivingthe reshaping of China’s healthcare industry profile.The Group always adheres to the corporate mission of“developing smart healthcare industry and promotingsmart healthy life”, moves forward actively, strives bravely,and continues developingthe three core technologies suchasbig data, artificial intelligence and cloud computing,to digitally boost the healthcare industry efficiency andreshaping. CHAIRMAN’S STATEMENT10 2023SIC10SICAI30SaaSAI-MDTAI20231231AI-MDT240AINLP Looking back to 2023, with joint efforts of all employees,the Group made historical highs in operating results,customer base, profitability,assets quality and otherindicators. Our SIC covered more than 100,000 chainp h a r m a c i e s ,a n d c o u l d i m p r o v e t h e e f f i c i e n c y o fbusiness operations for pharmacies through membershipmanagement, category management and other services.By virtue of SIC extensive coverage and deep linkage atpharmacy terminals,we helped medical product suppliersaccuratel